Saluda Medical Appoints Barry Regan as Chief Executive Officer
Pleasanton, CA – June 30, 2025 – Saluda Medical, a pioneering company dedicated to advancing neuromodulation therapies, today announced the appointment of Barry Regan as its new Chief Executive Officer. Mr. Regan brings a wealth of experience in the medical device industry, with a proven track record of leadership and success in driving innovation and commercial growth.
This strategic leadership appointment marks a significant milestone for Saluda Medical as the company continues to focus on the development and commercialization of its groundbreaking closed-loop spinal cord stimulation (SCS) system. The Evolver™ system, Saluda’s flagship product, is designed to revolutionize the treatment of chronic back and leg pain by providing a more personalized and adaptive therapeutic experience for patients.
“We are thrilled to welcome Barry Regan to Saluda Medical as our new CEO,” said [Name and Title of Board Chair/Previous CEO, if available, otherwise omit]. “Barry’s extensive experience in the medical technology sector, particularly his deep understanding of the neuromodulation market and his demonstrated ability to lead high-performing teams, makes him an ideal choice to guide Saluda Medical through its next phase of growth. His strategic vision and operational expertise will be invaluable as we continue to expand the reach of our innovative technology and improve the lives of patients suffering from chronic pain.”
Mr. Regan joins Saluda Medical from [Previous Company, if mentioned in article, otherwise omit], where he served as [Previous Role, if mentioned in article, otherwise omit]. During his tenure, he was instrumental in [mention a key achievement or area of expertise, if available, otherwise omit]. His career has been characterized by a strong commitment to patient-centric innovation and building robust commercial strategies.
“I am honored and excited to join Saluda Medical at this pivotal moment,” stated Barry Regan. “Saluda’s innovative closed-loop SCS technology represents a significant advancement in the treatment of chronic pain, offering a truly personalized approach that can potentially transform patient outcomes. I am eager to work with the talented team at Saluda to accelerate the adoption of the Evolver™ system and bring much-needed relief to more patients worldwide.”
Saluda Medical’s Evolver™ system is designed to continuously monitor a patient’s physiological response and automatically adjust stimulation parameters in real-time, aiming to optimize pain relief and reduce the need for manual adjustments. This adaptive technology holds the promise of delivering more consistent and effective pain management for individuals living with debilitating chronic pain conditions.
The appointment of Mr. Regan underscores Saluda Medical’s commitment to strong leadership and its strategic focus on delivering innovative solutions to the significant unmet needs in the chronic pain market. The company is well-positioned to capitalize on its technological advancements and expand its market presence under Mr. Regan’s leadership.
Saluda Medical Appoints Barry Regan as Chief Executive Officer
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
PR Newswire Healthring published ‘Saluda Medical Appoints Barry Regan as Chief Executive Officer’ at 2025-06-30 20:30. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.